Skip to main content
main-content

Cardiovascular disorders


Browse the latest news, expert commentary, and educational content on cardiovascular disorders.


Highlights

13-01-2022 | SGLT2 inhibitors | News

Residual cardiorenal risk high after SGLT2 inhibitor initiation in diabetic CKD

People with type 2 diabetes and chronic kidney disease have a high residual risk for cardiorenal events and high rates of treatment failure after initiation of SGLT2 inhibitors, real-world study findings indicate.

17-12-2021 | Heart failure | News

Metformin, but not sulfonylurea, may reduce poor outcome risk post HHF

Initiating metformin following hospitalization for heart failure may reduce the risk for death or further HHF in older people with comorbid diabetes, but only if they have a preserved ejection fraction, study findings indicate.

19-11-2021 | Finerenone | News

Finerenone reduces HF risk in people with type 2 diabetes and CKD

Finerenone reduces the risk for new-onset heart failure, as well as hospitalization for heart failure (HHF) and death from HF, in people with type 2 diabetes and albuminuric chronic kidney disease, the latest analysis of FIGARO-DKD study data show.

More on cardiovascular disorders

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits